Volume 179, Issue 7, July.-22
Editor’s Note
1. Neuroscientific Advances Supporting New Treatments for Major Depression
- Ned H. Kalin, M.D.
- Pages:441–444
- PDF
Editorials
2. Digital Therapeutics to Enhance Cognition in Major Depression: How Can We Make the Cognitive Gains Translate Into Functional Improvements?
- Philip D. Harvey, Ph.D.
- Pages:445–447
- PDF
3. Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?
- Alan F. Schatzberg, M.D.
- Pages:448–450
- PDF
4. Is Neuroplasticity Key to Treatment Response in Depression? Maybe So
- Fabio Ferrarelli, M.D., Ph.D.
- Pages:451–453
- PDF
5. The Amygdala and Depression: A Sober Reconsideration
- Shannon E. Grogans, M.S., Andrew S. Fox, Ph.D., Alexander J. Shackman, Ph.D.
- Pages:454–457
- PDF
Reviews and Overviews
6. Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?
- Diego A. Pizzagalli, Ph.D.
- Pages:458–469
- PDF
Articles
7. Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence
- Pedro Mario Pan, M.D., Ph.D., João R. Sato, Ph.D., Marie-Laure Paillère Martinot, M.D., Ph.D., Jean-Luc Martinot, M.D., Ph.D., Eric Artiges, M.D., Ph.D., Jani Penttilä, M.D., Ph.D., Yvonne Grimmer, M.D., Betteke M. van Noort, Ph.D., Andreas Becker, Ph.D., Dipl.-Psych., Tobias Banaschewski, M.D., Ph.D., Arun L. W. Bokde, Ph.D., Sylvane Desrivières, Ph.D., Herta Flor, Ph.D., Hugh Garavan, Ph.D., Bernd Ittermann, Ph.D., Frauke Nees, Ph.D., Dimitri Papadopoulos Orfanos, Ph.D., Luise Poustka, M.D., Juliane H. Fröhner, M.Sc., Robert Whelan, Ph.D., Gunter Schumann, M.D., Margaret L. Westwater, Ph.D., Christian Grillon, Ph.D., Hugo Cogo-Moreira, Ph.D., Argyris Stringaris, M.D., Ph.D., Monique Ernst, M.D., Ph.D., for the IMAGEN Consortium
- Pages:470–481
- PDF
8. Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults
- Richard S.E. Keefe, Ph.D., Elena Cañadas, Ph.D., Deborah Farlow, Ph.D., Amit Etkin, M.D., Ph.D.
- Pages:482–489
- PDF
9. Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial
- Herriot Tabuteau, M.D., Amanda Jones, Pharm.D., Ashley Anderson, B.S., Mark Jacobson, M.A., Dan V. Iosifescu, M.D.
- Pages:490–499
- PDF
10. Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial
- Ruiyang Ge, Ph.D., Afifa Humaira, B.Sc., Elizabeth Gregory, M.Sc., Golnoush Alamian, Ph.D., Erin L. MacMillan, Ph.D., Laura Barlow, R.T.R., R.T.M.R., Rebecca Todd, Ph.D., Sean Nestor, M.D., Ph.D., Sophia Frangou, M.D., Ph.D., Fidel Vila-Rodriguez, M.D., Ph.D.
- Pages:500–508
- PDF
Priority Data Letter
11. No Association Between Amygdala Responses to Negative Faces and Depressive Symptoms: Cross-Sectional Data from 28,638 Individuals in the UK Biobank Cohort
- Sandra Tamm, M.D., Ph.D., Catherine J. Harmer, Ph.D., Julian Schiel, M.Sc., Florian Holub, B.Sc., Martin K. Rutter, M.B.Ch.B., M.D., Kai Spiegelhalder, M.D., Ph.D., Simon D. Kyle, Ph.D.
- Pages:509–513
- PDF